MedTrace Logo

The Treatment of Premature Infants With Brain Injury by Autologous Umbilical Cord Blood Stem Cells

NCT03696745 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2018-10-05

No results posted yet for this study

Summary

To study the safety and effect of autologous umbilical cord blood stem cells for treatment brain injury

Conditions

  • Safety Issues
  • Effect of Drugs

Interventions

OTHER

autologous umbilical cord blood stem cells

autologous umbilical cord blood stem cells treatment for brain injury for safety and effect evaluation

DRUG

0.9% Sodium-chloride

0.9% Sodium-chloride in control group

Sponsors & Collaborators

  • Guangdong Women and Children Hospital

    lead OTHER

Principal Investigators

  • Jie Yang, PHD · Gunagzhou,Guangdong,China,511442

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
28 Weeks
Max Age
37 Weeks
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-11-01
Primary Completion
2020-09-01
Completion
2021-09-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03696745 on ClinicalTrials.gov